RedHill Biopharma raises maximum size of ATM ADS offering under H.C. Wainwright agreement
RedHill Biopharma filed a prospectus supplement raising the maximum aggregate amount of ADSs it may sell under its at-the-market offering program. The ADS sales are made from time to time under an equity distribution agreement with H.C. Wainwright entered on Feb. 3, 2025. Each ADS represents 10,000 ordinary shares. Dis